Hikma Pharmaceuticals PLC ORD SHS.../  GB00B0LCW083  /

London Domestic
2024-11-15  9:00:00 PM Chg. +22.0000 Volume Bid2024-11-15 Ask2024-11-15 Market Capitalization Dividend Y. P/E Ratio
1,816.0000GBX +1.23% 385,234
Turnover(GBP): 6.97 mill.
1,750.0000Bid Size: 410 2,000.0000Ask Size: 500 4.04 bill.GBP - -

Assets

2018
IFRS
in mill. USD
2019
IFRS
in mill. USD
2020
IFRS
in mill. USD
2021
IFRS
in mill. USD
2022
IFRS
in mill. USD
Property and Equipment
  870   912   1,009   1,146   1,081
Intangible Assets
  487   552   587   607   735
Long-Term Investments
  68   43   48   -   -
Fixed Assets
  1,829   2,082   2,213   2,278   2,472
Inventories
  528   568   757   695   776
Accounts Receivable
  731   719   756   816   809
Cash and Cash Equivalents
  276   442   323   426   270
Current Assets
  1,668   1,848   1,922   2,094   1,999
Total Assets
  3,497   3,930   4,135   4,372   4,471

 

Liabilities

2018
IFRS
in mill. USD
2019
IFRS
in mill. USD
2020
IFRS
in mill. USD
2021
IFRS
in mill. USD
2022
IFRS
in mill. USD
Accounts Payable
  465   473   470   468   476
Long-term debt
  539   48   692   725   1,135
Liabilities to Banks
  613   617   850   -   -
Provisions
  39   43   59   55   51
Liabilities
  1,800   1,801   1,987   1,905   2,323
Share Capital
  40   41   41   -   -
Total Equity
  1,685   2,117   2,135   2,453   2,135
Minority Interests
  12   12   13   14   13
Total liabilities equity
  3,497   3,930   4,135   4,372   4,471

 

Income Statement

2018
IFRS
in mill. USD
2019
IFRS
in mill. USD
2020
IFRS
in mill. USD
2021
IFRS
in mill. USD
2022
IFRS
in mill. USD
Revenues
  2,070   2,207   2,341   2,553   2,517
Depreciation (total)
  -   -   2   -   -
Operating Result
  371   493   579   582   282
Interest Income
  -   -   -   -39   -52
Income Before Taxes
  293   491   558   -   -
Income Taxes
  -8   -4   -128   124   42
Minority Interests Profit
  -4   -1   1   1   -3
Net Income
  282   486   431   421   188

 

Per Share

2018
IFRS
in USD
2019
IFRS
in USD
2020
IFRS
in USD
2021
IFRS
in USD
2022
IFRS
in USD
Earnings per Share
  1.1700   2.0080   1.8260   1.8230   0.8390
Dividend per Share
  0.3800   0.4400   0.5000   0.5400   0.5600

 

Cash Flow

2018
IFRS
in mill. USD
2019
IFRS
in mill. USD
2020
IFRS
in mill. USD
2021
IFRS
in mill. USD
2022
IFRS
in mill. USD
Cash Flow from Operating Activities
  430   472   464   638   530
Cash Flow from Investing Activities
  -96   -151   -283   -238   -607
Cash Flow from Financing
  -278   -155   -298   -287   -58
Decrease / Increase in Cash
  56   166   -117   -   -
Employees
  8,413   8,578   8,681   8,703   8,835